Filip Fratev
Filip Fratev
Micar 21 & The University of Texas at El Paso (UTEP)& IAU A79
Verified email at utep.edu - Homepage
Title
Cited by
Cited by
Year
Discovery of a Novel Selective PPARγ Ligand with Partial Agonist Binding Properties by Integrated in Silico/in Vitro Work Flow
I Kouskoumvekaki, RK Petersen, F Fratev, O Taboureau, TE Nielsen, ...
Journal of chemical information and modeling 53 (4), 923-937, 2013
262013
Activation helix orientation of the estrogen receptor is mediated by receptor dimerization: evidence from molecular dynamics simulations
F Fratev
Physical Chemistry Chemical Physics 17 (20), 13403-13420, 2015
252015
3D-QSAR and molecular mechanics study for the differences in the azole activity against yeastlike and filamentous fungi and their relation to P450DM inhibition. 1. 3 …
F Fratev, E Benfenati
Journal of chemical information and modeling 45 (3), 634-644, 2005
242005
Structural insight into the UNC‐45–myosin complex
F Fratev, S Ósk Jónsdóttir, I Pajeva
Proteins: Structure, Function, and Bioinformatics 81 (7), 1212-1221, 2013
182013
Molecular Basis of Inactive B-RAFWT and B-RAFV600E Ligand Inhibition, Selectivity and Conformational Stability: An in Silico Study
F Fratev, SÓ Jónsdóttir, E Mihaylova, I Pajeva
Molecular pharmaceutics 6 (1), 144-157, 2009
182009
QSAR models for Daphnia magna toxicity prediction of benzoxazinone allelochemicals and their transformation products
E Lo Piparo, F Fratev, F Lemke, P Mazzatorta, M Smiesko, JI Fritz, ...
Journal of agricultural and food chemistry 54 (4), 1111-1115, 2006
182006
Combination of genetic screening and molecular dynamics as a useful tool for identification of disease-related mutations: ZASP PDZ domain G54S mutation case
F Fratev, E Mihaylova, I Pajeva
Journal of chemical information and modeling 54 (5), 1524-1536, 2014
152014
A combination of 3D-QSAR, docking, local-binding energy (LBE) and GRID study of the species differences in the carcinogenicity of benzene derivatives chemicals
F Fratev, E Benfenati
Journal of Molecular Graphics and Modelling 27 (2), 147-160, 2008
152008
Toxicity study of allelochemical-like pesticides by a combination of 3D-QSAR, docking, Local Binding Energy (LBE) and GRID approaches
F Fratev, EL Piparo, E Benfenati, E Mihaylova
SAR and QSAR in Environmental Research 18 (7-8), 675-692, 2007
152007
Structural and dynamical insight into PPARγ antagonism: in silico study of the ligand-receptor interactions of non-covalent antagonists
F Fratev, I Tsakovska, M Al Sharif, E Mihaylova, I Pajeva
International journal of molecular sciences 16 (7), 15405-15424, 2015
142015
An in silico study of the molecular basis of B-RAF activation and conformational stability
FF Fratev, SÓ Jónsdóttir
BMC Structural Biology 9 (1), 47, 2009
142009
Prediction of Accurate Binding Modes using Combination of classical and accelerated Molecular dynamics and Free Energy Perturbation Calculations: An Application to Toxicity Studies
F Fratev, T Steinbrecher, SÖ Jònsdòttir
ACS Omega 3 (4), 4357-4371, 2018
112018
The phosphorylation specificity of B-RAFWT, B-RAFD594V, B-RAFV600E and B-RAFK601E kinases: An in silico study
F Fratev, SÓ Jónsdóttir
Journal of Molecular Graphics and Modelling 28 (7), 598-603, 2010
112010
Molecular dynamics simulation of the human estrogen receptor alpha: contribution to the pharmacophore of the agonists
D Jereva, F Fratev, I Tsakovska, P Alov, T Pencheva, I Pajeva
Mathematics and Computers in Simulation, 10.1016/j.matcom.2015.07.003, 2015
92015
Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling
S Adhikari, S Daftardar, F Fratev, M Rivera, S Sirimulla, K Alexander, ...
International journal of pharmaceutics 545 (1-2), 357-365, 2018
82018
PPARγ helix 12 exhibits an antagonist conformation
F Fratev
Physical Chemistry Chemical Physics 18 (13), 9272-9280, 2016
72016
Dust environment and dynamical history of a sample of short-period comets
FJ Pozuelos, F Moreno, F Aceituno, V Casanova, A Sota, ...
Astronomy & Astrophysics 568, A3, 2014
72014
PPARγ non-covalent antagonists exhibit mutable binding modes with a similar free energy of binding: A case study
F Fratev
Journal of Biomolecular Structure and Dynamics, 2016
62016
CoMFA study of non-peptide angiotensin II receptor (AT1) antagonist
F Fratev
Oxidation Communications 28 (1), 230-236, 2005
42005
An improved free energy perturbation FEP+ sampling protocol for flexible ligand-binding domains
F Fratev, S Sirimulla
Scientific reports 9 (1), 16829, 2019
32019
The system can't perform the operation now. Try again later.
Articles 1–20